Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications-Reference-Cited by-同舟云学术

Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications

Published:2016-02-19 Issue:3 Volume:14 Page:468-478
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Hazendonk H. C. A. M.¹^ORCID,Lock J.¹,Mathôt R. A. A.²,Meijer K.³,Peters M.⁴,Laros-van Gorkom B. A. P.⁵,van der Meer F. J. M.⁶,Driessens M. H. E.⁷,Leebeek F. W. G.⁸,Fijnvandraat K.⁴,Cnossen M. H.¹

Affiliation:

1. Department of Pediatric Hematology; Erasmus University Medical Center - Sophia Children's Hospital Rotterdam; Rotterdam the Netherlands

2. Hospital Pharmacy - Clinical Pharmacology; Academic Medical Center Amsterdam; Amsterdam the Netherlands

3. Department of Hematology; University of Groningen; University Medical Center Groningen; Groningen the Netherlands

4. Department of Pediatric Hematology; Academic Medical Center Amsterdam; Amsterdam the Netherlands

5. Department of Hematology; Radboud University Medical Center; Nijmegen the Netherlands

6. Department of Thrombosis and Hemostasis; Leiden University Medical Center; Leiden the Netherlands

7. Netherlands Hemophilia Patient Society (NVHP); Nijkerk the Netherlands

8. Department of Hematology; Erasmus University Medical Center Rotterdam; Rotterdam the Netherlands

Funder

Bayer

Baxter International

Pfizer

CSL Behring

Novo Nordisk

Bayer Schering

Novartis

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13242/fullpdf

Reference42 articles.

1. Diagnosis and management of haemophilia;Fijnvandraat;BMJ,2012

2. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A;Collins;J Thromb Haemost,2009

3. Costs of care in hemophilia and possible implications of health care reform;Johnson;Hematology Am Soc Hematol Educ Program,2011

4. Economics of prophylactic treatment;Schramm;Haemophilia,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients;Haemophilia;2024-02-11

2. Clinical Predictors and Prediction Models for rFVIII-Fc Half Life in Real-World People with Severe Hemophilia A;Journal of Clinical Medicine;2023-03-13

3. SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders;Journal of Thrombosis and Haemostasis;2022-09

4. Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature;Journal of Thrombosis and Haemostasis;2022-06

5. Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders;Thrombosis and Haemostasis;2022-05-31